NEUCA S.A. (WSE: NEU)
Poland
· Delayed Price · Currency is PLN 841.00
+35.00 (4.34%)
Sep 27, 2024, 5:00 PM CET
NEUCA Revenue
NEUCA had revenue of 3.04B PLN in the quarter ending June 30, 2024, with 5.26% growth. This brings the company's revenue in the last twelve months to 12.13B, up 4.04% year-over-year. In the year 2023, NEUCA had annual revenue of 11.81B with 5.17% growth.
Revenue (ttm)
12.13B
Revenue Growth
+4.04%
P/S Ratio
0.31
Revenue / Employee
2.62M
Employees
4,633
Market Cap
3.76B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 11.81B | 580.45M | 5.17% |
| Dec 31, 2022 | 11.23B | 1.37B | 13.87% |
| Dec 31, 2021 | 9.86B | 619.37M | 6.70% |
| Dec 31, 2020 | 9.24B | 972.52M | 11.76% |
| Dec 31, 2019 | 8.27B | 519.10M | 6.70% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Krka, d. d. | 8.06B |
| Sopharma AD | 4.35B |
| Synektik Spólka Akcyjna | 618.67M |
| Celon Pharma S.A. | 206.81M |
| Ryvu Therapeutics S.A. | 82.39M |
| Voxel S.A. | 476.19M |
| Selvita S.A. | 329.02M |
| Mercator Medical S.A. | 487.39M |